GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Cash and Bank History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash and Bank | ₹1,705 Cr | ₹1,659 Cr | ₹1,160 Cr | ₹1,412 Cr | ₹1,139 Cr |
What is the latest Cash and Bank ratio of GLENMARK PHARMACEUTICALS ?
| Year | Cash and Bank |
|---|---|
| Mar2025 | ₹1,705 Cr |
| Mar2024 | ₹1,659 Cr |
| Mar2023 | ₹1,160 Cr |
| Mar2022 | ₹1,412 Cr |
| Mar2021 | ₹1,139 Cr |
How is Cash and Bank of GLENMARK PHARMACEUTICALS Trending?
| Years | Cash and Bank | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,705 Cr | 2.76 | |
| Mar2024 | ₹1,659 Cr | 43.02 | |
| Mar2023 | ₹1,160 Cr | -17.80 | |
| Mar2022 | ₹1,412 Cr | 23.91 | |
| Mar2021 | ₹1,139 Cr | - | |
Compare Cash and Bank of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹57,275.3 Cr | -0.8% | 4.2% | 30.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,590.0 Cr | -2% | -6.1% | -6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,577.0 Cr | -0.8% | -0.8% | 8.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,301.0 Cr | 0% | 2.7% | 11% | Stock Analytics | |
| CIPLA | ₹120,471.0 Cr | -0.6% | -2.6% | 0.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,660.0 Cr | -1.3% | 0.6% | -6.4% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -0.8% |
4.2% |
30.2% |
| SENSEX | -1% |
-1.2% |
7.9% |
You may also like the below Video Courses